NCT06226311

Brief Summary

Globally 12.6 million people, including 1.7 million children under the age of 5, die each year from environmental-related illnesses. Prenatal exposure to environmental chemical pollutants has been associated with perinatal mortality, prematurity, low birth weight, congenital malformations, neurobehavioral function disorder and metabolic disorders. This project aims: a) to evaluate exposure to environmental pollutants during pregnancy; and, b) to study the association of this exposure with anthropometry and neurodevelopment of the offspring, up to 6 years of age. This study will be based on a population of 1000 pregnant women whose recruitment has already started under the IoMum project (clinical trials #NCT04010708), previously approved by Ethics Commitee of Centro Hospitalar e Universitário São João/Faculdade de Medicina da Universidade do Porto (#292-17). Maternal urine samples collected in the 1st and 3rd trimesters of pregnancy will be used. Maternal urinary concentrations of toxic metals and pesticide metabolites will be determined and neurodevelopmental outcomes will be evaluated as well as anthropometric parameters of children from birth to 6 years of age. The results of this project will contribute to the characterization of the exposure of Portuguese pregnant women to environmental pollutants as well as to the knowledge on the association between isolated or cumulative exposure to these pollutants and the health of the offspring.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
450

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Mar 2024

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 6, 2022

Completed
1.1 years until next milestone

First Posted

Study publicly available on registry

January 26, 2024

Completed
1 month until next milestone

Study Start

First participant enrolled

March 1, 2024

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2024

Completed
1.2 years until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2025

Completed
Last Updated

January 26, 2024

Status Verified

October 1, 2023

Enrollment Period

6 months

First QC Date

December 6, 2022

Last Update Submit

January 24, 2024

Conditions

Keywords

PregnancyChildhoodExposureEnvironmental PollutantsAnthropometry

Outcome Measures

Primary Outcomes (5)

  • Anthropometric measurements of children - Weight

    Information n the weight (in kilograms) of children aged between 3-4 and 5-6 years will be recorded

    The information will be collected at baseline by telephone contact (3-4 years of age) with parents or legal representatives or by direct, in person, measurement (5-6 years of age)

  • Anthropometric measurements of children - Height

    Information on the height (in centimeters) of children aged between 3-4 and 5-6 years will be recorded

    The information will be at baseline collected by telephone contact (3-4 years of age) with parents or legal representatives or by direct, in person, measurement (5-6 years of age)

  • Neurodevelopment scores of children

    Communication, daily life activities, socialization and motor skills will be assessed using the Vineland Adaptive Behavior Scale

    At 3-4 and 5-6 years old of the children, parents will answer a questionnaire regarding daily living, social, communication and motor skills adjusetd to the specific age group, at baseline

  • 1st trimester maternal urinary concentrations of environmental pollutants

    Median urinary concentations of 3-PBA, TCPY in micrograms per liter

    Between gestational weeks 10 and 13 plus 6 days (Timepoint 1)

  • 1st trimester maternal urinary concentrations of oligoelements

    Median urinary concentations of Pb, As, Cd, Li, Hg in micrograms per liter

    Between gestational weeks 10 and 13 plus 6 days (Timepoint 1)

Secondary Outcomes (7)

  • 1st trimester maternal urinary concentration of iodine

    Between gestational weeks 10 and 13 plus 6 days (Timepoint 1)

  • 3rd trimester maternal urinary concentration of environmental pollutants

    Between gestational weeks 37 and 40 plus 6 days (Timepoint 2)

  • 3rd trimester maternal urinary concentration of oligoelements

    Between gestational weeks 37 and 40 plus 6 days (Timepoint 2)

  • Anthropometric measures of the children at birth, 1, 2 and 4 years - Weight

    Birth, 1, 2 and 4 years of age (retrospectively collected at the same moment, during the first phone call)

  • Anthropometric measures of the children at birth, 1, 2 and 4 years - Height

    Birth, 1, 2 and 4 years of age (retrospectively collected at the same moment, during the first phone call)

  • +2 more secondary outcomes

Study Arms (1)

Children of IoMum pregnants cohort

IoMum participants without congenital malformations or gestational diabetes, with a singleton pregnancy with live birth, who provided contact and a T1 urine sample, will be invited to participate under signed informed consent.

Other: Data collectionOther: Diagnostic Test: Urinary

Interventions

Collection of sociodemographic, lifestyle and health data; Child anthropometry (weight, height and head circumference) at the ages of 3-4 and 5-6 years Child neurodevelopment scores at the ages of 3-4 and 5-6 years

Children of IoMum pregnants cohort

Trichloro-pyridinol (TCPy) and 3-phenoxybenzoic acid (3-PBA) Environemental oligoelements including Lithium (7Li), Arsenic (75As), Cadmium (111Cd), Lead (208Pb) and Mercury (80Hg)

Children of IoMum pregnants cohort

Eligibility Criteria

Age3 Years - 6 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)
Sampling MethodNon-Probability Sample
Study Population

The study population will be based on the 1155 pregnant women from the IoMum cohort, who have already been recruited at the Centro Hospitalar Universitário de São João (CHUSJ) and at CUF Descobertas Hospital (CUFD), Lisbon, in the 1st trimester ultrasound scan, as well as by the children born in this cohort.

You may qualify if:

  • Have had single live birth
  • Have provided contact and a urine sample T1
  • Have provided consent to participate at T1
  • Have provided consent to participate at T3

You may not qualify if:

  • Pregnancy complications
  • Congenital malformations
  • Gestational diabetes

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Faculty of Medicine (FMUP)

Porto, 4200-319, Portugal

Location

Biospecimen

Retention: SAMPLES WITH DNA

Urine samples

MeSH Terms

Interventions

Data Collection

Intervention Hierarchy (Ancestors)

Epidemiologic MethodsInvestigative TechniquesHealth Care Evaluation MechanismsQuality of Health CareHealth Care Quality, Access, and EvaluationPublic HealthEnvironment and Public Health

Study Officials

  • Elisa Keating, PhD

    Universidade do Porto

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 6, 2022

First Posted

January 26, 2024

Study Start

March 1, 2024

Primary Completion

September 1, 2024

Study Completion

December 1, 2025

Last Updated

January 26, 2024

Record last verified: 2023-10

Locations